Neurodegenerative Diseases

News

A new R&D project will try to develop assays for LRRK2, a biomarker linked to Parkinson's that has emerged as a major drug target in the disease.

News

An international trial has started to see if a simple finger-prick blood test could predict Alzheimer's before symptoms start.

News

Eli Lilly has agreed a $1.2bn takeover of Ventyx Bio and its clinical-stage drugs for inflammatory and cardiometabolic diseases.

News

AC Immune's active immunotherapy study backs up the alpha-synuclein hypothesis in Parkinson's disease, after disappointments in earlier trials.

News

VectorY has been cleared by the FDA to start human trials of a drug against a target implicated in up to 97% of amyotrophic lateral sclerosis cases.

R&D

On the emergence of brain organoids and the advent of automation, the latter being essential for high-throughput approaches drug development demands.